Modulation of Neurexins Alternative Splicing by Cannabinoid Receptors 1 (CB1) Signaling.

Area of Science:

• Neuroscience
• Molecular Biology
• Synaptic Plasticity

Background:

• Synaptic plasticity, crucial for learning and memory, involves pre-synaptic neurexins (Nrxns) and the endocannabinoid system.
• Neurexins undergo alternative splicing, generating diverse isoforms that modulate synaptic interactions.
• The endocannabinoid system regulates synaptic plasticity via retrograde signaling.

Purpose of the Study:

• To investigate the interplay between neurexin alternative splicing and the endocannabinoid system in the hippocampus.
• To understand how cannabinoid receptor 1 (CB1) signaling affects Nrxn splicing patterns.
• To elucidate the functional consequences of this crosstalk on neurotransmission.

Main Methods:

• Utilized an ex vivo hippocampal system.
• Pharmacologically modulated CB1 receptor activity using ACEA (agonist) and AM251 (antagonist).
• Analyzed Nrxn splicing variants and neurotransmission levels.
• Investigated the role of splicing factor SLM2 through knockout (ko) experiments.

Main Results:

• CB1 activation (ACEA) reduced neurotransmission and increased Nrxn isoforms lacking exon SS4 (SS4-).
• CB1 antagonism (AM251) increased glutamatergic activity and Nrxn isoforms including exon SS4 (SS4+).
• SLM2 knockout abolished Nrxn splicing modulation by CB1 ligands and disrupted neurotransmission responses.

Conclusions:

• A direct crosstalk exists between CB1 signaling, neurotransmission, and specific Nrxn splice variants in the hippocampus.
• Regulation of Nrxn alternative splicing by the endocannabinoid system may provide feedback control of neurotransmission.
• Fine-tuned Nrxn splicing is critical for adapting synaptic function to endocannabinoid system activity.